- Asian Physician's Perspectives on Biosimilars in Inflammatory Bowel Disease: Are We Ready to Use?
-
Na SY
- KMID: 2469903
- Korean J Gastroenterol.
- 2019 Dec;74(6):301-303.
- doi: 10.4166/kjg.2019.74.6.301
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Knowledge and Viewpoints on Biosimilar Monoclonal Antibodies among Asian Physicians: Comparison with European Physicians
-
Park SK, Moon W, Kim ES, Park SH, Park DI
- KMID: 2469908
- Korean J Gastroenterol.
- 2019 Dec;74(6):333-340.
- doi: 10.4166/kjg.2019.74.6.333
BACKGROUND/AIMS: Current knowledge and viewpoints regarding biosimilars among physicians in Asia are unknown, even though these were investigated by European Crohn's and Colitis Organization (ECCO) members in 2013 and 2015.... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis
-
Midha V, Mahajan R, Mehta V, Narang V, Singh A, Kaur K, Sood A
- KMID: 2402651
- Intest Res.
- 2018 Jan;16(1):83-89.
- doi: 10.5217/ir.2018.16.1.83
BACKGROUND/AIMS: Data on the efficacy and safety of the adalimumab biosimilar Exemptia are limited. METHODS: Patients with moderate-to-severe active steroid-refractory ulcerative colitis (UC) treated at Dayanand Medical College and Hospital, India... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the Safety and Efficacy of Abcertin(R) in Patients with Type 1 Gaucher Disease
-
Choi JH, Lee BH, Ko JM, Sohn YB, Lee JS, Kim GH, Heo SH, Park JY, Kim YM, Kim JH, Yoo HW
- KMID: 2164444
- J Korean Med Sci.
- 2015 Apr;30(4):378-384.
- doi: 10.3346/jkms.2015.30.4.378
Gaucher disease is a lysosomal storage disease for which enzyme replacement therapy has proven to be effective. A switch-over clinical trial was performed to evaluate the efficacy and safety of... -
- CITED
-
- Close
- SHARE
-
- Close
- Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia
-
Ooi CJ, Hilmi I, Banerjee R, Chuah SW, Ng SC, Wei SC, Makharia G, Pisespongsa P, Chen MH, Ran ZH, Ye BD, Park DI, Ling KL, Ong D, Ahuja V, Goh KL, Sollano J, Lim WC, Leung WK, Ali RA, Wu DC, Ong E, Mustaffa N, Limsrivilai J, Hisamatsu , Yang SK, Ouyang Q, Geary R, De Silva J, Rerknimitr R, Simadibrata M, Abdullah M, Leong RW, on behalf of the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn's and Colitis
- KMID: 2454738
- Intest Res.
- 2019 Jul;17(3):285-310.
- doi: 10.5217/ir.2019.00026
The Asia-Pacific Working Group on inflammatory bowel disease (IBD) was established in Cebu, Philippines, under the auspices of the Asian Pacific Association of Gastroenterology with the goal of improving IBD... -
- CITED
-
- Close
- SHARE
-
- Close
